- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
6
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
6 companies
AstraZeneca
Market Cap: UK£210.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£139.10
7D
3.3%
1Y
35.7%
Gilead Sciences
Market Cap: US$155.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.05
7D
-1.7%
1Y
16.7%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,500.00
7D
-2.0%
1Y
-1.0%
Orion Oyj
Market Cap: €9.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€69.55
7D
2.0%
1Y
10.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥39.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥93.50
7D
12.6%
1Y
-1.2%
Xiamen Amoytop Biotech
Market Cap: CN¥22.2b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥54.75
7D
0.3%
1Y
-24.0%